Incyte (INCY) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 6:06Sector: Healthcare
The share price of Incyte Corp. (INCY) now
What analysts predict:: $92
52-week high/low: $88.26 / $61.91
50/200 Day Moving Average: $76.95 / $72.14
This figure corresponds to the average price over the previous 50/200 days. For Incyte stocks, the 50-day moving average is the resistance level today.
For Incyte stocks, the 200-day moving average is the support level today.
Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2022, 2023, 2024, 2025, 2026. How much will one Incyte share be worth in 2022 - 2026?
When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock?
We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.
Historical and forecast chart of Incyte stock
The chart below shows the historical price of Incyte stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.
Long-term forecasts by years.
Incyte daily forecast for a month
Incyte Daily Price Targets
Incyte Stock Forecast 05-22-2022.
Pessimistic target level: 74.88
Optimistic target level: 76.49
Incyte Stock Forecast 05-23-2022.
Pessimistic target level: 74.03
Optimistic target level: 77.24
Incyte Stock Forecast 05-24-2022.
Pessimistic target level: 72.75
Optimistic target level: 75.40
Incyte Stock Forecast 05-25-2022.
Pessimistic target level: 73.15
Optimistic target level: 75.37
Incyte Stock Forecast 05-26-2022.
Pessimistic target level: 73.32
Optimistic target level: 75.73
Incyte Stock Forecast 05-27-2022.
Pessimistic target level: 73.56
Optimistic target level: 75.67
INCY (INCY) Monthly Stock Prediction for 2022
Incyte forecast for this year
Incyte Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $77.0571. Pessimistic: $71.72. Optimistic: $79.55
Incyte Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $75.6701. Pessimistic: $72.26. Optimistic: $77.37
Incyte Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $76.4192. Pessimistic: $72.64. Optimistic: $78.48
Incyte Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $74.1496. Pessimistic: $71.95. Optimistic: $75.55
Incyte Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $75.4843. Pessimistic: $71.82. Optimistic: $78.07
Incyte Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $80.9871. Pessimistic: $78.65. Optimistic: $86.53
Incyte Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $83.8297. Pessimistic: $78.62. Optimistic: $87.75
Incyte (INCY) Monthly Stock Prediction for 2023
Incyte (INCY) Monthly Stock Prediction for 2024
Incyte (INCY) Monthly Stock Prediction for 2025
Incyte (INCY) Monthly Stock Prediction for 2026
Incyte information and performance
Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US
Market Capitalization: 16 590 724 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 659 659 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 17.54
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 0.628
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 2.755
Quarterly Revenue Growth YOY: 0.093
Trailing PE: 17.54
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 20.75
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.453
Enterprise Value (EV) /Revenue
EV To EBITDA: 21.87
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 221505000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.